The report considers the evolution and needs of the modern, global, sterile, pharmaceutical manufacturing industry and addresses the ongoing confusion surrounding regulatory expectations for the use of Restricted Access Barrier Systems (RABS) in the manufacture of sterile pharmaceuticals….
